NEWS 19 March 2024 Modified protein-design tool could make it easier to tackle challenging drug targets — but AI antibodies are still a long way from reaching the clinic. Ewen Callaway Antibodies (pink) bind to influenza virus proteins (yellow) (artist’s conception).Credit: Juan Gaertner/Science Photo Library Researchers have used generative artificial intelligence (AI) to help them make completely new antibodies for the first time.The proof-of-principle work, reported this week in a preprint on...